These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12537087)

  • 21. ["Tissue engineering": Cultivated heart valves are still a future vision].
    Fath R
    Dtsch Med Wochenschr; 2003 Apr; 128(17):912. PubMed ID: 12749352
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of animal models in developing the discipline of cardiovascular tissue engineering: a review.
    Rashid ST; Salacinski HJ; Hamilton G; Seifalian AM
    Biomaterials; 2004 Apr; 25(9):1627-37. PubMed ID: 14697864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of: application of synthetic scaffold in tissue engineering heart valves.
    Fallahiarezoudar E; Ahmadipourroudposht M; Idris A; Mohd Yusof N
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():556-65. PubMed ID: 25579957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Umbilical cord cells as a source of cardiovascular tissue engineering.
    Breymann C; Schmidt D; Hoerstrup SP
    Stem Cell Rev; 2006; 2(2):87-92. PubMed ID: 17237546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro heart valve tissue engineering.
    Schmidt D; Mol A; Kelm JM; Hoerstrup SP
    Methods Mol Med; 2007; 140():319-30. PubMed ID: 18085217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Homograft in the therapy of cardiovascular diseases].
    Striffeler H; Kipfer B; Althaus U; Carrel T
    Praxis (Bern 1994); 1997 Mar; 86(12):476-81. PubMed ID: 9148386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiac and vascular homograft valves transplant].
    Herreros JM; Mastrobuoni S; Ubilla M; Rábago G; Lorente Ruiz M; Rifón J; Hernández M
    An Sist Sanit Navar; 2006; 29 Suppl 2():153-61. PubMed ID: 16998523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of stem cells for cardiovascular grafts tissue engineering.
    Wu K; Liu YL; Cui B; Han Z
    Transpl Immunol; 2006 Jun; 16(1):1-7. PubMed ID: 16701169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of decellularized xenogeneic tissue in heart valve replacement.
    Stock UA; Schenke-Layland K
    Biomaterials; 2006 Jan; 27(1):1-2. PubMed ID: 16026824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioreactor technology in cardiovascular tissue engineering.
    Mertsching H; Hansmann J
    Adv Biochem Eng Biotechnol; 2009; 112():29-37. PubMed ID: 19290496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioreactors for development of tissue engineered heart valves.
    Berry JL; Steen JA; Koudy Williams J; Jordan JE; Atala A; Yoo JJ
    Ann Biomed Eng; 2010 Nov; 38(11):3272-9. PubMed ID: 20820920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cells used for cardiovascular tissue engineering.
    Siepe M; Akhyari P; Lichtenberg A; Schlensak C; Beyersdorf F
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):242-7. PubMed ID: 18468449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering blood vessels by gene and cell therapy.
    Zarbiv G; Preis M; Ben-Yosef Y; Flugelman MY
    Expert Opin Biol Ther; 2007 Aug; 7(8):1183-91. PubMed ID: 17696817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves.
    Perry TE; Kaushal S; Sutherland FW; Guleserian KJ; Bischoff J; Sacks M; Mayer JE
    Ann Thorac Surg; 2003 Mar; 75(3):761-7; discussion 767. PubMed ID: 12645690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute.
    Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE
    Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell-derived vasculature: A potent and multidimensional technology for basic research, disease modeling, and tissue engineering.
    Lowenthal J; Gerecht S
    Biochem Biophys Res Commun; 2016 May; 473(3):733-42. PubMed ID: 26427871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Getting to the heart of tissue engineering.
    Khait L; Hecker L; Blan NR; Coyan G; Migneco F; Huang YC; Birla RK
    J Cardiovasc Transl Res; 2008 Mar; 1(1):71-84. PubMed ID: 20559960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric cardiovascular grafts: historical perspective and future directions.
    Heydrick S; Roberts E; Kim J; Emani S; Wong JY
    Curr Opin Biotechnol; 2016 Aug; 40():119-124. PubMed ID: 27046072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue engineering of heart valves in vivo using bone marrow-derived cells.
    Kim SS; Lim SH; Hong YS; Cho SW; Ryu JH; Chang BC; Choi CY; Kim BS
    Artif Organs; 2006 Jul; 30(7):554-7. PubMed ID: 16836737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo tissue engineering of heart valves: evolution of a novel concept.
    Schleicher M; Wendel HP; Fritze O; Stock UA
    Regen Med; 2009 Jul; 4(4):613-9. PubMed ID: 19580409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.